85 related articles for article (PubMed ID: 19200636)
1. Stem cell characteristics in prostate cancer cell lines.
Pfeiffer MJ; Schalken JA
Eur Urol; 2010 Feb; 57(2):246-54. PubMed ID: 19200636
[TBL] [Abstract][Full Text] [Related]
2. [Sorting and identification of cancer stem cells in human prostate cancer cell lines].
Luo Y; Cui XH; Jiang YG; Zhao JH; Zhao L; Chen YT; Li MC; Lin YH
Zhonghua Nan Ke Xue; 2012 Dec; 18(12):1062-8. PubMed ID: 23405783
[TBL] [Abstract][Full Text] [Related]
3. The effect of culture conditions on colony morphology and proliferative capacity in human prostate cancer cell lines.
Beaver CM
Cell Biol Toxicol; 2012 Oct; 28(5):291-301. PubMed ID: 22790656
[TBL] [Abstract][Full Text] [Related]
4. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
Li H; Chen X; Calhoun-Davis T; Claypool K; Tang DG
Cancer Res; 2008 Mar; 68(6):1820-5. PubMed ID: 18339862
[TBL] [Abstract][Full Text] [Related]
5. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics.
Bisson I; Prowse DM
Cell Res; 2009 Jun; 19(6):683-97. PubMed ID: 19365403
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
7. The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells.
Gruber M; Handle F; Culig Z
Prostate; 2020 Feb; 80(3):267-273. PubMed ID: 31834633
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of human prostate carcinoma cell lines.
van Bokhoven A; Varella-Garcia M; Korch C; Johannes WU; Smith EE; Miller HL; Nordeen SK; Miller GJ; Lucia MS
Prostate; 2003 Nov; 57(3):205-25. PubMed ID: 14518029
[TBL] [Abstract][Full Text] [Related]
9. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer.
Freedland SJ; Seligson DB; Liu AY; Pantuck AJ; Paik SH; Horvath S; Wieder JA; Zisman A; Nguyen D; Tso CL; Palotie AV; Belldegrun AS
Prostate; 2003 Apr; 55(1):71-80. PubMed ID: 12640663
[TBL] [Abstract][Full Text] [Related]
10. Aldehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells.
Doherty RE; Haywood-Small SL; Sisley K; Cross NA
Biochem Biophys Res Commun; 2011 Nov; 414(4):801-7. PubMed ID: 22005464
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.
Horiguchi A; Zheng R; Shen R; Nanus DM
Prostate; 2008 Jun; 68(9):975-84. PubMed ID: 18361411
[TBL] [Abstract][Full Text] [Related]
12. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.
Zhang K; Waxman DJ
Mol Cancer; 2010 Dec; 9():319. PubMed ID: 21190562
[TBL] [Abstract][Full Text] [Related]
13. Identification of nestin-positive putative mammary stem cells in human breastmilk.
Cregan MD; Fan Y; Appelbee A; Brown ML; Klopcic B; Koppen J; Mitoulas LR; Piper KM; Choolani MA; Chong YS; Hartmann PE
Cell Tissue Res; 2007 Jul; 329(1):129-36. PubMed ID: 17440749
[TBL] [Abstract][Full Text] [Related]
14. Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones.
Gallagher MF; Salley Y; Spillane CD; Ffrench B; El Baruni S; Blacksheilds G; Smyth P; Martin C; Sheils O; Watson W; O'Leary JJ
J Clin Pathol; 2015 Sep; 68(9):692-702. PubMed ID: 26038242
[TBL] [Abstract][Full Text] [Related]
15. Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells.
Tan L; Sui X; Deng H; Ding M
PLoS One; 2011; 6(8):e23383. PubMed ID: 21826251
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of stem cell marker gene expression in canine prostate carcinoma- and prostate cyst-derived cell lines.
Moulay M; Liu W; Willenbrock S; Sterenczak KA; Carlson R; Ngezahayo A; Murua Escobar H; Nolte I
Anticancer Res; 2013 Dec; 33(12):5421-31. PubMed ID: 24324078
[TBL] [Abstract][Full Text] [Related]
17. Clonogenicity: holoclones and meroclones contain stem cells.
Beaver CM; Ahmed A; Masters JR
PLoS One; 2014; 9(2):e89834. PubMed ID: 24587067
[TBL] [Abstract][Full Text] [Related]
18. Characterization of autoimmune inflammation induced prostate stem cell expansion.
Wang HH; Wang L; Jerde TJ; Chan BD; Savran CA; Burcham GN; Crist S; Ratliff TL
Prostate; 2015 Oct; 75(14):1620-31. PubMed ID: 26174474
[TBL] [Abstract][Full Text] [Related]
19. CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line.
Rajabi Fomeshi M; Ebrahimi M; Mowla SJ; Firouzi J; Khosravani P
Cell J; 2016; 18(1):21-7. PubMed ID: 27054115
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of p63 Protein and Sonic Hedgehog Signaling Molecule in Buccal Epithelial Holoclones.
Buhl M; Kloskowski T; Jundzill A; Szeliski K; Rasmus M; Dąbrowski P; Siedlecka N; Drewa T; Pokrywczynska M
Stem Cells Dev; 2021 Oct; 30(20):1037-1048. PubMed ID: 34486385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
